Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRMD |
---|---|---|
09:32 ET | 6782 | 4.21 |
09:34 ET | 200 | 4.23 |
09:41 ET | 100 | 4.22 |
09:43 ET | 1700 | 4.22 |
09:45 ET | 300 | 4.22 |
09:48 ET | 300 | 4.22 |
09:50 ET | 100 | 4.22 |
09:52 ET | 500 | 4.22 |
09:54 ET | 200 | 4.21 |
09:56 ET | 3330 | 4.2 |
09:57 ET | 600 | 4.18 |
10:01 ET | 400 | 4.1763 |
10:03 ET | 4121 | 4.1857 |
10:06 ET | 300 | 4.195 |
10:10 ET | 3395 | 4.2 |
10:17 ET | 100 | 4.215 |
10:19 ET | 100 | 4.215 |
10:21 ET | 100 | 4.215 |
10:24 ET | 100 | 4.215 |
10:28 ET | 109 | 4.21 |
10:30 ET | 236 | 4.22 |
10:32 ET | 1981 | 4.2 |
10:37 ET | 400 | 4.21 |
10:39 ET | 300 | 4.205 |
10:42 ET | 22547 | 4.215 |
10:44 ET | 4058 | 4.21 |
10:46 ET | 600 | 4.19 |
10:50 ET | 19292 | 4.21 |
10:51 ET | 400 | 4.205 |
10:53 ET | 100 | 4.205 |
10:55 ET | 1100 | 4.21 |
10:57 ET | 2400 | 4.23 |
11:00 ET | 1600 | 4.215 |
11:06 ET | 2515 | 4.245 |
11:09 ET | 100 | 4.255 |
11:11 ET | 100 | 4.2575 |
11:15 ET | 1258 | 4.25 |
11:20 ET | 200 | 4.255 |
11:22 ET | 822 | 4.245 |
11:24 ET | 100 | 4.24 |
11:27 ET | 300 | 4.235 |
11:31 ET | 1151 | 4.235 |
11:33 ET | 100 | 4.235 |
11:36 ET | 5400 | 4.235 |
11:38 ET | 700 | 4.2375 |
11:44 ET | 100 | 4.2375 |
11:45 ET | 200 | 4.235 |
11:47 ET | 100 | 4.2375 |
11:49 ET | 1100 | 4.225 |
11:54 ET | 100 | 4.2299 |
11:56 ET | 300 | 4.225 |
11:58 ET | 200 | 4.225 |
12:03 ET | 1100 | 4.225 |
12:07 ET | 250 | 4.225 |
12:09 ET | 300 | 4.23 |
12:12 ET | 200 | 4.225 |
12:14 ET | 144 | 4.2285 |
12:18 ET | 2304 | 4.225 |
12:20 ET | 100 | 4.225 |
12:25 ET | 200 | 4.215 |
12:30 ET | 200 | 4.21 |
12:32 ET | 100 | 4.2175 |
12:34 ET | 500 | 4.21 |
12:38 ET | 330 | 4.22 |
12:39 ET | 1300 | 4.215 |
12:41 ET | 100 | 4.21 |
12:43 ET | 100 | 4.21 |
12:45 ET | 100 | 4.21 |
12:48 ET | 400 | 4.215 |
12:50 ET | 1936 | 4.215 |
12:52 ET | 1244 | 4.235 |
12:54 ET | 114 | 4.2303 |
12:56 ET | 200 | 4.24 |
12:59 ET | 100 | 4.235 |
01:03 ET | 100 | 4.235 |
01:06 ET | 3400 | 4.235 |
01:08 ET | 266 | 4.24 |
01:12 ET | 713 | 4.255 |
01:14 ET | 300 | 4.26 |
01:15 ET | 200 | 4.26 |
01:24 ET | 234 | 4.265 |
01:26 ET | 100 | 4.265 |
01:28 ET | 1508 | 4.265 |
01:30 ET | 100 | 4.27 |
01:35 ET | 750 | 4.265 |
01:37 ET | 400 | 4.265 |
01:39 ET | 700 | 4.27 |
01:42 ET | 722 | 4.265 |
01:44 ET | 215 | 4.2759 |
01:48 ET | 500 | 4.28 |
01:50 ET | 500 | 4.275 |
01:51 ET | 2439 | 4.27 |
01:57 ET | 300 | 4.275 |
02:00 ET | 2705 | 4.26 |
02:02 ET | 100 | 4.265 |
02:04 ET | 100 | 4.265 |
02:08 ET | 200 | 4.27 |
02:09 ET | 100 | 4.265 |
02:11 ET | 100 | 4.265 |
02:15 ET | 1443 | 4.275 |
02:18 ET | 225 | 4.28 |
02:20 ET | 100 | 4.28 |
02:22 ET | 1540 | 4.265 |
02:24 ET | 900 | 4.265 |
02:26 ET | 300 | 4.26 |
02:27 ET | 100 | 4.265 |
02:31 ET | 200 | 4.265 |
02:36 ET | 2200 | 4.26 |
02:42 ET | 100 | 4.265 |
02:44 ET | 100 | 4.265 |
02:47 ET | 200 | 4.265 |
02:49 ET | 1868 | 4.235 |
02:51 ET | 100 | 4.235 |
02:54 ET | 300 | 4.24 |
02:56 ET | 900 | 4.24 |
03:00 ET | 100 | 4.245 |
03:02 ET | 1828 | 4.235 |
03:07 ET | 200 | 4.24 |
03:09 ET | 100 | 4.235 |
03:12 ET | 100 | 4.235 |
03:16 ET | 700 | 4.235 |
03:18 ET | 1100 | 4.235 |
03:20 ET | 100 | 4.235 |
03:21 ET | 100 | 4.235 |
03:23 ET | 4457 | 4.23 |
03:25 ET | 4661 | 4.235 |
03:27 ET | 2807 | 4.245 |
03:32 ET | 1035 | 4.24 |
03:34 ET | 1600 | 4.235 |
03:38 ET | 100 | 4.2375 |
03:39 ET | 500 | 4.235 |
03:41 ET | 100 | 4.235 |
03:43 ET | 700 | 4.235 |
03:45 ET | 200 | 4.235 |
03:48 ET | 4235 | 4.225 |
03:50 ET | 100 | 4.225 |
03:52 ET | 1094 | 4.225 |
03:54 ET | 1975 | 4.21 |
03:56 ET | 15080 | 4.2 |
03:57 ET | 9848 | 4.18 |
03:59 ET | 7489 | 4.18 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
CorMedix Inc | 229.8M | -4.5x | --- |
Cipla Ltd | 14.5B | 0.0x | --- |
Zevra Therapeutics Inc | 192.1M | -3.4x | --- |
Calliditas Therapeutics AB | 1.2B | -20.9x | --- |
Assembly Biosciences Inc | 94.2M | -1.4x | --- |
Incannex Healthcare Inc | 53.5M | 0.0x | --- |
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $229.8M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.59 |
EPS | $-0.93 |
Book Value | $1.28 |
P/E Ratio | -4.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.